Skip to main content
. 2023 Nov 29;6(11):e2344194. doi: 10.1001/jamanetworkopen.2023.44194

Table 1. Baseline Demographic, Alzheimer Disease Biomarker, and Neuropsychological Performance Characteristics for All Women and by HIV Serostatus.

Characteristic Participants, No. (%)a P value
All (N = 307) WLWH (n = 209) WLWOH (n = 98)
Age range, y
40-49 13 (4) 0 13 (13) <.001
50-59 159 (52) 108 (52) 51 (52)
≥60 135 (44) 101 (48) 34 (35)
Race
African American or Black 164 (53) 111 (53) 53 (54) .04
White 35 (11) 30 (14) 5 (5)
Otherb 108 (35) 68 (33) 40 (41)
Ethnicity
Hispanic 65 (21) 43 (21) 22 (22) .82
Non-Hispanic 242 (79) 166 (79) 76 (78)
Education
Less than high school 93 (30) 63 (30) 30 (31) >.99
High school or higher 214 (70) 146 (70) 68 (69)
Annual income, $
≤12 000 154 (50) 103 (49) 51 (52) .68
>12 000 152 (50) 106 (51) 46 (47)
Tobacco use
Never smoker 69 (22) 53 (25) 16 (16) .11
Current or former smoker 238 (78) 156 (75) 82 (84)
Marijuana use
Never smoker 253 (82) 178 (85) 75 (77) .09
Current or former smoker 54 (18) 31 (15) 23 (23)
Drinking history
Abstainer or none 164 (53) 118 (56) 46 (47) .19
Low to moderate 133 (43) 86 (41) 47 (48)
High 10 (3) 5 (2) 5 (5)
Other drug use (crack, cocaine, or heroin)
Yes 18 (6) 11 (5) 7 (7) .69
No 289 (94) 198 (95) 91 (93)
Hypertension
Yes 166 (54) 117 (56) 49 (50) .83
No 121 (39) 83 (40) 38 (39)
Type 2 diabetes
Yes 101 (33) 67 (32) 34 (35) .65
No 206 (67) 142 (68) 64 (65)
Body mass indexc
Healthy (18.5-24.9) 69 (22) 51 (24) 18 (18) .001
Overweight (25.0-29.9) 94 (31) 75 (36) 19 (19)
Obese (≥30) 142 (46) 83 (40) 59 (60)
Estimated glomerular filtration rate, mL/min/1.73 m2
<30 13 (4) 8 (4) 5 (5) .02
30-44.9 12 (4) 7 (3) 5 (5)
45-59.9 33 (11) 30 (14) 3 (3)
≥60 249 (81) 164 (78) 85 (87)
Neurological measures
Memory loss
Yes 21 (7) 13 (6) 8 (9) .70
No 286 (93) 196 (94) 90 (92)
Numbness or tingling hands and feet
Yes 69 (22) 42 (20) 27 (28) .19
No 238 (78) 167 (80) 71 (72)
Confusion or getting lost
Yes 12 (4) 9 (4) 3 (3) .76
No 295 (96) 200 (96) 95 (97)
Center for Epidemiological Studies-Depression scale score
<16 225 (73) 157 (75) 68 (69) .43
≥16 81 (26) 52 (25) 29 (30)
HIV variables
CD4 T cell count, cells/mL -
<200 NA 10 (5) NA NA
200-499 NA 148 (71) NA
≥500 NA 51 (24) NA
HIV RNA viral load, copies/mL
Viral load undetectable (<80) NA 181 (87) NA NA
Viral load detectable (≥80), median (IQR) NA 1130 (188-6270) NA
Taking antiretroviral therapy
Yes NA 150 (72) NA NA
No NA 58 (28) NA
History of AIDS
Yes NA 108 (52) NA NA
No NA 101 (48) NA
Neuropsychological performance assessments, T-score, mean (SD)d
Executive function 49.6 (9.4) 49.1 (9.8) 50.7 (8.2) .15
Processing speed 49.2 (10.6) 48.8 (10.7) 50.1 (10.4) .30
Attention 48.5 (9.3) 48.7 (9.5) 48.2 (9.0) .68
Learning 48.9 (11.2) 47.8 (11.3) 51.4 (10.5) .009
Memory 49.6 (11.4) 48.3 (11.6) 52.4 (10.2) .002
Verbal fluency 49.1 (9.4) 48.3 (9.8) 50.7 (8.5) .03
Motor 49.6 (11.6) 49.5 (11.2) 49.9 (12.6) .80
Global 49.8 (6.6) 49.2 (6.8) 51.1 (5.9) .02

Abbreviations: NA, not available; WLWH, women living with HIV; WLWOH, women living without HIV.

a

Variables reported as No. (%) were analyzed with χ2 tests.

b

Other race was defined as American Indian or Native Alaskan, Asian, Native Hawaiian or Pacific Islander, and multiracial.

c

Body mass index was calculated as weight in kilograms divided by height in meters squared.

d

T-scores are demographically adjusted for age, education, Wide Range Achievement Test reading subtest score, race (African American vs White or other race), and ethnicity (Hispanic vs non-Hispanic).